iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) Shares Bought by Clarus Wealth Advisors

Clarus Wealth Advisors increased its stake in shares of iShares Nasdaq Biotechnology ETF (NASDAQ:IBB) by 2,076.7% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 5,224 shares of the financial services provider’s stock after buying an additional 4,984 shares during the quarter. Clarus Wealth Advisors’ holdings in iShares Nasdaq Biotechnology ETF were worth $584,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Parkside Financial Bank & Trust purchased a new stake in iShares Nasdaq Biotechnology ETF in the 4th quarter worth approximately $29,000. Sontag Advisory LLC purchased a new stake in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter valued at $32,000. Aspire Private Capital LLC purchased a new stake in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter valued at $40,000. Genesee Capital Advisors LLC purchased a new stake in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter valued at $42,000. Finally, Intercontinental Wealth Advisors LLC purchased a new stake in shares of iShares Nasdaq Biotechnology ETF during the 4th quarter valued at $56,000. 66.61% of the stock is currently owned by hedge funds and other institutional investors.

Shares of iShares Nasdaq Biotechnology ETF stock opened at $107.40 on Friday. iShares Nasdaq Biotechnology ETF has a twelve month low of $89.01 and a twelve month high of $122.97.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Baseball Daily News and is the property of of Baseball Daily News. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.baseballdailydigest.com/news/2019/04/27/ishares-nasdaq-biotechnology-etf-ibb-position-increased-by-clarus-wealth-advisors.html.

iShares Nasdaq Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.

Recommended Story: What Is An Exchange-Traded Fund (ETF)?

Institutional Ownership by Quarter for iShares Nasdaq Biotechnology ETF (NASDAQ:IBB)

Receive News & Ratings for iShares Nasdaq Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Nasdaq Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.